Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
J Psychosoc Oncol ; 41(2): 182-195, 2023.
Article in English | MEDLINE | ID: mdl-35703090

ABSTRACT

To assess COVID-19-pandemic related anxiety and emotional-behavioral difficulties among oncologic children and their caregivers.Prospective cohort study conducted from March to November 2020.76 pediatric oncological and 28 nonmalignant hematological patients aged 1.6-23.4 years and their caregivers.A total of 104 families completed an age-specific self-report psychological assessment; of these, 20 oncologic families completed the assessment at two time points.Ten percent of the caregivers and 13.9% of the patients reported anxiety disorder. Additionally, 3.1% of the caregivers reported behavioral difficulties. No significant differences emerged between patients' self-reports and caregivers' reports. No differences emerged between oncological and nonmalignant hematological participants.The prevalence of anxiety associated with the COVID-19 pandemic was similar to the reported prevalence of anxiety following a diagnosis of pediatric malignancy.Real-time assessment of psychological effects revealed no COVID-19-associated anxiety. Nonetheless, late effects will need to be monitored.


Subject(s)
COVID-19 , Neoplasms , Child , Humans , COVID-19/epidemiology , Caregivers/psychology , Pandemics , Prospective Studies , Cohort Studies , Anxiety/psychology , Neoplasms/psychology , Anxiety Disorders/epidemiology
2.
Sci Rep ; 9(1): 17760, 2019 11 28.
Article in English | MEDLINE | ID: mdl-31780802

ABSTRACT

Altered metabolism is a hallmark of cancer, but little is still known about its regulation. In this study, we measure transcriptomic, proteomic, phospho-proteomic and fluxomics data in a breast cancer cell-line (MCF7) across three different growth conditions. Integrating these multiomics data within a genome scale human metabolic model in combination with machine learning, we systematically chart the different layers of metabolic regulation in breast cancer cells, predicting which enzymes and pathways are regulated at which level. We distinguish between two types of reactions, directly and indirectly regulated. Directly-regulated reactions include those whose flux is regulated by transcriptomic alterations (~890) or via proteomic or phospho-proteomics alterations (~140) in the enzymes catalyzing them. We term the reactions that currently lack evidence for direct regulation as (putative) indirectly regulated (~930). Many metabolic pathways are predicted to be regulated at different levels, and those may change at different media conditions. Remarkably, we find that the flux of predicted indirectly regulated reactions is strongly coupled to the flux of the predicted directly regulated ones, uncovering a tiered hierarchical organization of breast cancer cell metabolism. Furthermore, the predicted indirectly regulated reactions are predominantly reversible. Taken together, this architecture may facilitate rapid and efficient metabolic reprogramming in response to the varying environmental conditions incurred by the tumor cells. The approach presented lays a conceptual and computational basis for mapping metabolic regulation in additional cancers.


Subject(s)
Breast Neoplasms/metabolism , Metabolic Networks and Pathways , Breast Neoplasms/enzymology , Breast Neoplasms/genetics , Cell Proliferation , Female , Humans , MCF-7 Cells , Machine Learning , Phosphorylation , Proteomics , Transcriptome
3.
Nat Immunol ; 16(7): 737-45, 2015 Jul.
Article in English | MEDLINE | ID: mdl-26006015

ABSTRACT

Aire is a transcriptional regulator that induces the promiscuous expression of thousands of tissue-restricted antigens (TRAs) in medullary thymic epithelial cells (mTECs), a step critical for the induction of immunological self-tolerance. Studies have offered molecular insights into how Aire operates, but more comprehensive understanding of this process still remains elusive. Here we found abundant expression of the protein deacetylase Sirtuin-1 (Sirt1) in mature Aire(+) mTECs, wherein it was required for the expression of Aire-dependent TRA-encoding genes and the subsequent induction of immunological self-tolerance. Our study elucidates a previously unknown molecular mechanism for Aire-mediated transcriptional regulation and identifies a unique function for Sirt1 in preventing organ-specific autoimmunity.


Subject(s)
Central Tolerance/immunology , Sirtuin 1/immunology , Transcription Factors/immunology , Transcriptional Activation/immunology , Acetylation , Animals , Antigens/immunology , Central Tolerance/genetics , Epithelial Cells/immunology , Epithelial Cells/metabolism , Flow Cytometry , HEK293 Cells , Humans , Immunoblotting , Interleukin Receptor Common gamma Subunit/deficiency , Interleukin Receptor Common gamma Subunit/genetics , Mice, Inbred C57BL , Mice, Inbred NOD , Mice, Knockout , Mice, SCID , Mice, Transgenic , Oligonucleotide Array Sequence Analysis , Organ Specificity/immunology , Protein Binding/immunology , Reverse Transcriptase Polymerase Chain Reaction , Sirtuin 1/genetics , Sirtuin 1/metabolism , Thymus Gland/cytology , Thymus Gland/immunology , Thymus Gland/metabolism , Transcription Factors/genetics , Transcription Factors/metabolism , Transcriptome/immunology , AIRE Protein
4.
Proc Natl Acad Sci U S A ; 111(19): 7006-11, 2014 May 13.
Article in English | MEDLINE | ID: mdl-24778235

ABSTRACT

p53 is a well-known tumor suppressor that is mutated in over 50% of human cancers. These mutations were shown to exhibit gain of oncogenic function compared with the deletion of the gene. Additionally, p53 has fundamental roles in differentiation and development; nevertheless, mutant p53 mice are viable and develop malignant tumors only on adulthood. We set out to reveal the mechanisms by which embryos are protected from mutant p53-induced transformation using ES cells (ESCs) that express a conformational mutant of p53. We found that, despite harboring mutant p53, the ESCs remain pluripotent and benign and have relatively normal karyotype compared with ESCs knocked out for p53. Additionally, using high-content RNA sequencing, we show that p53 is transcriptionally active in response to DNA damage in mutant ESCs and elevates p53 target genes, such as p21 and btg2. We also show that the conformation of mutant p53 protein in ESCs is stabilized to a WT conformation. Through MS-based interactome analyses, we identified a network of proteins, including the CCT complex, USP7, Aurora kinase, Nedd4, and Trim24, that bind mutant p53 and may shift its conformation to a WT form. We propose this conformational shift as a novel mechanism of maintenance of genomic integrity, despite p53 mutation. Harnessing the ability of these protein interactors to transform the oncogenic mutant p53 to the tumor suppressor WT form can be the basis for future development of p53-targeted cancer therapy.


Subject(s)
Cell Transformation, Neoplastic/genetics , Embryonic Stem Cells/cytology , Li-Fraumeni Syndrome/genetics , Tumor Suppressor Protein p53/chemistry , Tumor Suppressor Protein p53/genetics , Adenocarcinoma , Animals , Breast Neoplasms , Cell Line , Cell Line, Tumor , Cell Proliferation , Embryonic Development/genetics , Embryonic Stem Cells/physiology , Homeodomain Proteins/genetics , Humans , Li-Fraumeni Syndrome/metabolism , Loss of Heterozygosity/physiology , Mice , Mice, Knockout , Nanog Homeobox Protein , Protein Conformation , Proteomics , Tumor Suppressor Protein p53/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...